Cargando…
Mucosal Vaccines for Biodefense
Bioterrorism is the deliberate release of biological toxins, pathogenic viruses, bacteria, parasites, or other infectious agents into the public sphere with the objective of causing panic, illness, and/or death on a local, regional, or possibly national scale. The list of potential biological agents...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121805/ https://www.ncbi.nlm.nih.gov/pubmed/21461982 http://dx.doi.org/10.1007/82_2011_122 |
_version_ | 1783515283111018496 |
---|---|
author | Mantis, N. J. Morici, L. A. Roy, C. J. |
author_facet | Mantis, N. J. Morici, L. A. Roy, C. J. |
author_sort | Mantis, N. J. |
collection | PubMed |
description | Bioterrorism is the deliberate release of biological toxins, pathogenic viruses, bacteria, parasites, or other infectious agents into the public sphere with the objective of causing panic, illness, and/or death on a local, regional, or possibly national scale. The list of potential biological agents compiled by the Centers for Disease Control and Prevention is long and diverse. However, a trait common to virtually all the potential bioterrorism agents is the fact that they are likely to be disseminated by either aerosol or in food/water supplies with the intention of targeting the mucosal surfaces of the respiratory or gastrointestinal tracts, respectively. In some instances, inhalation or ingestion would mimic the natural route by which humans are exposed to these agents. In other instances, (e.g., the inhalation of a toxin is normally associated with food borne illness), it would represent an unnatural route of exposure. For most potential bioterrorism agents, the respiratory or gastrointestinal mucosa may simply serve as a route of entry by which they gain access to the systemic compartment where intoxication/replication occurs. For others, however, the respiratory or gastrointestinal mucosa is the primary tissue associated with pathogenesis, and therefore, the tissue for which countermeasures must be developed. |
format | Online Article Text |
id | pubmed-7121805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71218052020-04-06 Mucosal Vaccines for Biodefense Mantis, N. J. Morici, L. A. Roy, C. J. Mucosal Vaccines Article Bioterrorism is the deliberate release of biological toxins, pathogenic viruses, bacteria, parasites, or other infectious agents into the public sphere with the objective of causing panic, illness, and/or death on a local, regional, or possibly national scale. The list of potential biological agents compiled by the Centers for Disease Control and Prevention is long and diverse. However, a trait common to virtually all the potential bioterrorism agents is the fact that they are likely to be disseminated by either aerosol or in food/water supplies with the intention of targeting the mucosal surfaces of the respiratory or gastrointestinal tracts, respectively. In some instances, inhalation or ingestion would mimic the natural route by which humans are exposed to these agents. In other instances, (e.g., the inhalation of a toxin is normally associated with food borne illness), it would represent an unnatural route of exposure. For most potential bioterrorism agents, the respiratory or gastrointestinal mucosa may simply serve as a route of entry by which they gain access to the systemic compartment where intoxication/replication occurs. For others, however, the respiratory or gastrointestinal mucosa is the primary tissue associated with pathogenesis, and therefore, the tissue for which countermeasures must be developed. 2011-04-03 /pmc/articles/PMC7121805/ /pubmed/21461982 http://dx.doi.org/10.1007/82_2011_122 Text en © Springer-Verlag Berlin Heidelberg 2011 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Mantis, N. J. Morici, L. A. Roy, C. J. Mucosal Vaccines for Biodefense |
title | Mucosal Vaccines for Biodefense |
title_full | Mucosal Vaccines for Biodefense |
title_fullStr | Mucosal Vaccines for Biodefense |
title_full_unstemmed | Mucosal Vaccines for Biodefense |
title_short | Mucosal Vaccines for Biodefense |
title_sort | mucosal vaccines for biodefense |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121805/ https://www.ncbi.nlm.nih.gov/pubmed/21461982 http://dx.doi.org/10.1007/82_2011_122 |
work_keys_str_mv | AT mantisnj mucosalvaccinesforbiodefense AT moricila mucosalvaccinesforbiodefense AT roycj mucosalvaccinesforbiodefense |